MacroGenics to Participate in Upcoming Investor Conferences


ROCKVILLE, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in November and December:

Continued here:
MacroGenics to Participate in Upcoming Investor Conferences

Related Posts